Methods for Development of the European Commission Initiative on Breast Cancer Guidelines Recommendations in the Era of Guideline Transparency

Autor: Schunemann, HJ, Lerda, D, Dimitrova, N, Alonso-Coello, P, Grawingholt, A, Quinn, C, Follmann, M, Mansel, R, Sardanelli, F, Rossi, PG, Lebeau, A, Nystrom, L, Broeders, M, Ioannidou-Mouzaka, L, Duffy, SW, Borisch, B, Fitzpatrick, P, Hofvind, S, Castells, X, Giordano, L, Warman, S, Saz-Parkinson, Z, Autelitan, M, Colzani, E, Danes, J, Knox, S, Langendam, M, McGarrigle, H, Gomez, EP, Torresin, A, van Engen, R, Young, K, van Landsveld-Verhoeven, C, Rigau, D, Sola, I, Ballesteros, M, Arevalo-Rodriguez, I, Posso, M, Garcia, LM, Canelo-Aybar, C, de Guzman, EN, Valli, C, Ricci-Cabello, I, Superchi, C, Piggott, T, Baldeh, T, Parmelli, E, European Comm Initiative Breast

Publikováno v: ANNALS OF INTERNAL MEDICINE
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname

Neither breast cancer prevention and early-detection programs, nor their outcomes, are uniform across Europe. This article describes the rationale, methods, and process for development of the European Commission ( EC) Initiative on Breast Cancer Scre

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::22699e236368a98adf635523fb3eb8b6
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=2508

Increased Saliva Oestriol To Progesterone Ratio Before Idiopathic Preterm Delivery: A Possible Predictor For Preterm Labour?

Autor: Darne, J., McGarrigle, H. H. G., Lachelin, Gillian C. L.

Publikováno v: British Medical Journal (Clinical Research Edition), 1987 Jan . 294(6567), 270-272.

Externí odkaz: https://www.jstor.org/stable/29525889

Recommendations from the European Commission Initiative on Breast Cancer for multigene testing to guide the use of adjuvant chemotherapy in patients with early breast cancer, hormone receptor positive, HER-2 negative.

Autor: Giorgi Rossi P; Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, Reggio Emilia, Italy., Lebeau A; Department of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Canelo-Aybar C; Iberoamerican Cochrane Center, Biomedical Research Institute (IIB Sant Pau-CIBERESP), Barcelona, Spain.; Department of Paediatrics, Obstetrics and Gynaecology, Preventive Medicine, and Public Health, PhD Programme in Methodology of Biomedical Research and Public Health, Universitat Autònoma de Barcelona, Bellaterra, Spain., Saz-Parkinson Z; European Commission, Joint Research Centre (JRC), Ispra, Italy. zuleika.saz-parkinson@ec.europa.eu.; Instituto de Salud Carlos III, Health Technology Assessment Agency, Avenida Monforte de Lemos 5, Madrid, Spain. zuleika.saz-parkinson@ec.europa.eu., Quinn C; St. Vincent's University Hospital, Dublin, Ireland., Langendam M; Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Amsterdam UMC, University of Amsterdam, Amsterdam Public Health Institute, Amsterdam, The Netherlands., Mcgarrigle H; Cardiff and Vale UHB - General Surgery, Cardiff, UK., Warman S; Havyatt Lodge, Havyatt Road, Langford, North Somerset, UK., Rigau D; Iberoamerican Cochrane Center, Biomedical Research Institute (IIB Sant Pau-CIBERESP), Barcelona, Spain., Alonso-Coello P; Iberoamerican Cochrane Center, Biomedical Research Institute (IIB Sant Pau-CIBERESP), Barcelona, Spain., Broeders M; Department for Health Evidence, Radboud University Medical Center, Nijmegen, the Netherlands.; Dutch Expert Centre for Screening, Nijmegen, the Netherlands., Graewingholt A; Radiologie am Theater, Paderborn, NRW, Germany., Posso M; Iberoamerican Cochrane Center, Biomedical Research Institute (IIB Sant Pau-CIBERESP), Barcelona, Spain.; Department of Epidemiology and Evaluation, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.; Research Network on Health Services in Chronic Diseases (REDISSEC), Barcelona, Spain., Duffy S; Centre for Cancer Prevention, Queen Mary University of London, Charterhouse Square, London, UK., Schünemann HJ; Michael G. DeGroote Cochrane Canada and McGRADE Centres; Department of Health Research Methods, Evidence and Impact, McMaster University Health Sciences Centre, Hamilton, Ontario, Canada.

Publikováno v: British journal of cancer [Br J Cancer] 2021 Apr; Vol. 124 (9), pp. 1503-1512. Date of Electronic Publication: 2021 Feb 18.

Development and use of health outcome descriptors: a guideline development case study.

Autor: Baldeh T; Department of Health Research Methodology, Evidence and Impact, Michael G. DeGroote Cochrane Canada and GRADE Centres, McMaster University, 1280 Main Street West, Hamilton, ON, L8N 4K1, Canada.; Michael G. DeGroote Cochrane Canada and MacGRADE Centres, 1280 Main Street West, Hamilton, Ontario, L8S 4K1, Canada., Saz-Parkinson Z; European Commission, Joint Research Centre (JRC), Via E. Fermi 2749 - TP 127, I-21027, Ispra, VA, Italy., Muti P; Department of Health Research Methodology, Evidence and Impact, Michael G. DeGroote Cochrane Canada and GRADE Centres, McMaster University, 1280 Main Street West, Hamilton, ON, L8N 4K1, Canada.; Department of Oncology, McMaster University, Hamilton, Canada., Santesso N; Department of Health Research Methodology, Evidence and Impact, Michael G. DeGroote Cochrane Canada and GRADE Centres, McMaster University, 1280 Main Street West, Hamilton, ON, L8N 4K1, Canada.; Michael G. DeGroote Cochrane Canada and MacGRADE Centres, 1280 Main Street West, Hamilton, Ontario, L8S 4K1, Canada.; Cochrane GRADEing Methods Group, 1280 Main Street West, Hamilton, Ontario, L8S 4K1, Canada., Morgano GP; Department of Health Research Methodology, Evidence and Impact, Michael G. DeGroote Cochrane Canada and GRADE Centres, McMaster University, 1280 Main Street West, Hamilton, ON, L8N 4K1, Canada.; Michael G. DeGroote Cochrane Canada and MacGRADE Centres, 1280 Main Street West, Hamilton, Ontario, L8S 4K1, Canada., Wiercioch W; Department of Health Research Methodology, Evidence and Impact, Michael G. DeGroote Cochrane Canada and GRADE Centres, McMaster University, 1280 Main Street West, Hamilton, ON, L8N 4K1, Canada.; Michael G. DeGroote Cochrane Canada and MacGRADE Centres, 1280 Main Street West, Hamilton, Ontario, L8S 4K1, Canada., Nieuwlaat R; Department of Health Research Methodology, Evidence and Impact, Michael G. DeGroote Cochrane Canada and GRADE Centres, McMaster University, 1280 Main Street West, Hamilton, ON, L8N 4K1, Canada.; Michael G. DeGroote Cochrane Canada and MacGRADE Centres, 1280 Main Street West, Hamilton, Ontario, L8S 4K1, Canada., Gräwingholt A; European Commission Initiative on Breast Cancer Guidelines Development Group, European Commission, JRC, Ispra, Italy.; Private Group Practice for Radiology, Radiologie am Theater, Paderborn, Germany., Broeders M; European Commission Initiative on Breast Cancer Guidelines Development Group, European Commission, JRC, Ispra, Italy.; Department for Health Evidence, Radboud University Medical Center, PO Box 9101, 6525 EZ, HB, Nijmegen, The Netherlands.; Dutch Expert Centre for Screening, PO Box 6873, 6503, GJ, Nijmegen, the Netherlands., Duffy S; European Commission Initiative on Breast Cancer Guidelines Development Group, European Commission, JRC, Ispra, Italy.; Centre for Cancer Prevention, Queen Mary University of London, Charterhouse Square, London, EC1M 6BQ, United Kingdom., Hofvind S; European Commission Initiative on Breast Cancer Guidelines Development Group, European Commission, JRC, Ispra, Italy.; Cancer Registry of Norway, PO 5313, Majorstua, 0304, Oslo, Norway.; Oslo Metropolitan University, Pilestredet 48, 0167, Oslo, Norway., Nystrom L; European Commission Initiative on Breast Cancer Guidelines Development Group, European Commission, JRC, Ispra, Italy.; Umeå University, 90187, Umeå, Sweden., Ioannidou-Mouzaka L; European Commission Initiative on Breast Cancer Guidelines Development Group, European Commission, JRC, Ispra, Italy.; Leto Gynecological-Surgical and Obstetrical Clinic, 18, Avenue Kifissias, 11526, Athens, Greece., Warman S; European Commission Initiative on Breast Cancer Guidelines Development Group, European Commission, JRC, Ispra, Italy., McGarrigle H; European Commission Initiative on Breast Cancer Guidelines Development Group, European Commission, JRC, Ispra, Italy.; Cardiff and Vale Breast Centre, University Hospital Llandough, Llandough, United Kingdom., Knox S; European Commission Initiative on Breast Cancer Guidelines Development Group, European Commission, JRC, Ispra, Italy.; EUROPA DONNA - The European Breast Cancer Coalition, Piazza Amendola 3, 20149, Milan, Italy., Fitzpatrick P; European Commission Initiative on Breast Cancer Guidelines Development Group, European Commission, JRC, Ispra, Italy.; National Screening Service, Kings Inns House, 200 Parnell Street, Dublin, D01 A3Y8, Ireland., Rossi PG; European Commission Initiative on Breast Cancer Guidelines Development Group, European Commission, JRC, Ispra, Italy.; Epidemiology Unit, Azienda Unità Sanitaria Locale - IRCCS di Reggio Emilia, Via Amendola 2, 42122, Reggio Emilia, Italy., Quinn C; European Commission Initiative on Breast Cancer Guidelines Development Group, European Commission, JRC, Ispra, Italy.; School of Medicine, University College Dublin, BreastCheck, Irish National Breast Screening Programme, St. Vincent's University Hospital, Elm Park, Dublin 4, Ireland., Borisch B; European Commission Initiative on Breast Cancer Guidelines Development Group, European Commission, JRC, Ispra, Italy.; Insitute of Global Health, University of Geneva, chemin des Mines 9, 1202, Geneva, Switzerland., Lebeau A; European Commission Initiative on Breast Cancer Guidelines Development Group, European Commission, JRC, Ispra, Italy.; Department of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany., de Wolf C; European Commission Initiative on Breast Cancer Guidelines Development Group, European Commission, JRC, Ispra, Italy., Langendam M; Cochrane GRADEing Methods Group, 1280 Main Street West, Hamilton, Ontario, L8S 4K1, Canada.; European Commission Initiative on Breast Cancer Guidelines Development Group, European Commission, JRC, Ispra, Italy.; Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Amsterdam UMC, University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands., Piggott T; Department of Health Research Methodology, Evidence and Impact, Michael G. DeGroote Cochrane Canada and GRADE Centres, McMaster University, 1280 Main Street West, Hamilton, ON, L8N 4K1, Canada., Giordano L; European Commission Initiative on Breast Cancer Guidelines Development Group, European Commission, JRC, Ispra, Italy.; CPO Piedmont-AOU Citta della Salute e della Scienza, via Cavour 31, 10131, Turin, Italy., van Landsveld-Verhoeven C; European Commission Initiative on Breast Cancer Guidelines Development Group, European Commission, JRC, Ispra, Italy.; Dutch Expert Centre for Screening, PO Box 6873, 6503, GJ, Nijmegen, the Netherlands., Bernier J; European Commission Initiative on Breast Cancer Guidelines Development Group, European Commission, JRC, Ispra, Italy., Rabe P; European Commission Initiative on Breast Cancer Guidelines Development Group, European Commission, JRC, Ispra, Italy., Schünemann HJ; Department of Health Research Methodology, Evidence and Impact, Michael G. DeGroote Cochrane Canada and GRADE Centres, McMaster University, 1280 Main Street West, Hamilton, ON, L8N 4K1, Canada. schuneh@mcmaster.ca.; Michael G. DeGroote Cochrane Canada and MacGRADE Centres, 1280 Main Street West, Hamilton, Ontario, L8S 4K1, Canada. schuneh@mcmaster.ca.; Cochrane GRADEing Methods Group, 1280 Main Street West, Hamilton, Ontario, L8S 4K1, Canada. schuneh@mcmaster.ca.; European Commission Initiative on Breast Cancer Guidelines Development Group, European Commission, JRC, Ispra, Italy. schuneh@mcmaster.ca.; Department of Medicine, McMaster University, 1280 Main Street West, Hamilton, Ontario, L8S 4K1, Canada. schuneh@mcmaster.ca.

Publikováno v: Health and quality of life outcomes [Health Qual Life Outcomes] 2020 Jun 05; Vol. 18 (1), pp. 167. Date of Electronic Publication: 2020 Jun 05.

A descriptive model of shared decision making derived from routine implementation in clinical practice ('Implement-SDM'): Qualitative study.

Autor: Joseph-Williams N; Cardiff University, College of Biomedical and Life Sciences, School of Medicine, Division of Population Medicine, Cardiff, UK. Electronic address: josephnj1@cardiff.ac.uk., Williams D; Cardiff University, College of Biomedical and Life Sciences, School of Medicine, Division of Population Medicine, Cardiff, UK., Wood F; Cardiff University, College of Biomedical and Life Sciences, School of Medicine, Division of Population Medicine, Cardiff, UK., Lloyd A; Cardiff University, College of Biomedical and Life Sciences, Centre for Trials Research, Cardiff, UK., Brain K; Cardiff University, College of Biomedical and Life Sciences, School of Medicine, Division of Population Medicine, Cardiff, UK., Thomas N; Pre dialysis Team, Cardiff and Vale University Health Board, Nephrology and Transplant Directorate, University Hospital of Wales, Cardiff, UK., Prichard A; Pre dialysis Team, Cardiff and Vale University Health Board, Nephrology and Transplant Directorate, University Hospital of Wales, Cardiff, UK., Goodland A; Pre dialysis Team, Cardiff and Vale University Health Board, Nephrology and Transplant Directorate, University Hospital of Wales, Cardiff, UK., McGarrigle H; Cardiff Breast Centre, Cardiff and Vale University Health Board, University Hospital Llandough, Cardiff, UK., Sweetland H; Cardiff Breast Centre, Cardiff and Vale University Health Board, University Hospital Llandough, Cardiff, UK., Edwards A; Cardiff University, College of Biomedical and Life Sciences, School of Medicine, Division of Population Medicine, Cardiff, UK.

Publikováno v: Patient education and counseling [Patient Educ Couns] 2019 Oct; Vol. 102 (10), pp. 1774-1785. Date of Electronic Publication: 2019 Jul 15.